The settlement resolves allegations that Oklahoma Center for Orthopaedic and Multi-Specialty Surgery and its management company made improper payments to Oklahoma City-based Southwest Orthopaedic Specialists and some of its physicians in exchange for patient referrals. The payments were allegedly provided in the form of free or below fair market value office space, compensation in excess of fair market value, equity buyback provisions and preferential investment opportunities.
The allegedly improper payments occurred between 2006 and 2018 and resulted in the submission of false claims to Medicare, Medicaid and Tricare, according to the Justice Department.
The allegations were originally brought in a lawsuit filed under the qui tam, or whistleblower, provisions of the False Claims Act.
More articles on legal and regulatory issues:
California surgeon charged in $600M billing fraud scheme
Former hospital executive charged in $1.4B billing scheme
Ex-Georgia hospital CEO, board member sentenced on federal charges
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
